ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "practice guidelines"

  • Abstract Number: 1960 • ACR Convergence 2022

    Impact of Delaying Initiation of Methotrexate by One Month on the Outcome of RA at One Year

    Theresa Than1, Emmanuelle Dernis2, Olivier BROCQ3, Bruno Fautrel4, Helena HUGUET5, Liana Euller-Ziegler6, Lindsay BUSTAMENTE-CENCI6, Olivier Vittecoq7, Marie-christine PICOT5, Cédric Lukas8, Claire DAIEN9, Charlotte Hua10, Marlène Genty5, Helene Che5, Anouck REMY-MOULARD11, Frederic LIOTE12, Martin Soubrier13, Cécile GAUJOUX-VIALA14, Arnaud Constantin15, Alain Saraux16, Emilie Ducourau17, Stephanie RIST18, CARINE SALLIOT19, Nada IBRAHIM-NASSER18, Clara qUINTEN18, Vincent Goeb20 and Jacques Morel1, 1University and CHU Montpellier, Montpellier, France, 2LE MANS general hospital, LE MANS, France, 3Centre hospitalier Princesse-Grace, Monaco, France, 4Sorbonne University Paris, France and Pierre Louis Institute of Epidemiology and Public Health, Paris, France, Paris, France, 5CHU Montpellier, Montpellier, France, 6CHRU Nice, Nice, France, 7CHU de Rouen, ROUEN, France, 8University Hospital Centre Montpellier, University of Montpellier, Montpellier, France, 9University Hospital, Saint-Gély-du-Fesc, France, 10La Lettre du Rhumatologue, Paris, France, 11CHU Montpellier, Montpellier, Chad, 12University of Paris, Paris, France, 13Gabriel-Montpied Hospital, Clermont-Ferrand, France, 14CHU Nîmes, Univ Montpellier (IDESP), Nîmes, France, 15Toulouse University Hospital, Toulouse, France, 16CHU Brest, Brest, France, 17CH Orleans, Chambray Les Tours, France, 18CH orleans, Orleans, France, 19CHR orleans, Orleans, France, 20CHU Amiens, Amiens, France

    Background/Purpose: It is recommended that vaccinations should be performed prior to start methotrexate (MTX) knowing that delaying initiation of background therapy may have an impact…
  • Abstract Number: 0666 • ACR Convergence 2021

    Process Mapping Gout Hospitalizations: A Deep Dive into an Avoidable Epidemic

    Mark Russell1, Benjamin Ellis2, Benjamin Clarke1, Deepak Nagra1 and James Galloway3, 1King's College London, London, United Kingdom, 2Imperial College Healthcare NHS Trust, London, United Kingdom, 3Kings College London, London, United Kingdom

    Background/Purpose: Hospital admissions for gout flares have increased dramatically in recent years. Strategies to reduce hospitalizations and improve uptake of urate-lowering therapy (ULT) are needed.…
  • Abstract Number: 1038 • ACR Convergence 2021

    Outcomes of Hydroxychloroquine Screening for Retinopathy in a Cohort of Patients with Rheumatological Conditions

    Ghazala Tehseen1, Alexandra Chadwick2, Sarah Wills2 and Audrey Low2, 1Faculty of Biology, Medicine and Health. The University of Manchester, Manchester, UK, Manchester, United Kingdom, 2Rheumatology Department, Salford Royal NHS Foundation Trust, Manchester, United Kingdom

    Background/Purpose: Hydroxychloroquine (HCQ) is used to treat rheumatoid arthritis (RA), connective tissue disease (CTD) and other inflammatory conditions. In 2018, the United Kingdom Royal College…
  • Abstract Number: 1587 • ACR Convergence 2021

    Do Physical Therapists Use Recommended Treatments for Chronic Low Back Pain?

    Debbie Feldman1, Jonathan El-Khoury2, Tatiana Orozco1, François Desmeules3, Maude Laliberté1 and Kadija Perreault4, 1Université de Montréal, Montréal, QC, Canada, 2Université de Sherbrooke, Sherbrooke, QC, Canada, 3Research Centre of Hôpital Maisonneuve Rosemont, Montréal, QC, Canada, 4Université Laval, Québec City, QC, Canada

    Background/Purpose: Chronic low back pain has been the subject of many studies in medicine and physical therapy for over half a century. Clinical practice guidelines…
  • Abstract Number: 1123 • ACR Convergence 2020

    The Patient Journey in Knee OA: Variations in Patient Characteristics and Treatment by Physician Specialty

    Angela Bedenbaugh1, Vinson Lee1, Gary Oderda2, Sarah Kennedy1, Diana Brixner2, Jeyanesh Tambiah3 and Timothy McAlindon4, 1Samumed, LLC, San Diego, CA, 2University of Utah, Salt Lake City, UT, 3Samumed LLC, San Diego, CA, 4Tufts Medical Center, Boston, MA

    Background/Purpose: Knee osteoarthritis (OA) affects 32.5 million US adults and is typically treated by primary care physicians, rheumatologists (RH), orthopedists (OS), sports medicine (SM) physicians,…
  • Abstract Number: 1623 • ACR Convergence 2020

    Improving Pneumococcal Vaccination Rates Among Immunosuppressed Adults in an Academic Rheumatology Clinic Utilizing a Nurse Driven Protocol

    Elena Joerns1, Bonnie Bermas2, Puneet Bajaj3, Nagendra Pokala1, Reuben Arasaratnam4, Joan Reisch1 and Dan (Clarie) Wang1, 1University of Texas Southwestern Medical Center, Dallas, TX, 2UTSouthwestern.edu, Dallas, TX, 3UT Southwestern, Dallas, TX, 4UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: Rheumatology patients are particularly vulnerable to pneumococcal infection due to both their underlying disease and immunosuppressive therapy. Thus, quality improvement metrics include increasing pneumococcal…
  • Abstract Number: 0019 • ACR Convergence 2020

    Lasting COVID-19 Impacts on US Rheumatology Practices

    Lynn Price1, Gianna Melendez1 and Phil Pouliot1, 1spherix global insights, Exton, PA

    Background/Purpose: In late 2019, a novel, highly contagious coronavirus (COVID-19), was discovered in China and quickly spread throughout the world, equating to arguably the largest…
  • Abstract Number: 0109 • ACR Convergence 2020

    Glucocorticoid-Induced Osteoporosis: Are We Practicing Prevention?

    Eileen Rife1, Emejuaiwe Nkechinyere2 and Jose Leon de la Rocha3, 1Louisiana State University, Metairie, LA, 2Department of Veterans Affairs, New Orleans, LA, 3Louisiana State University, Auburn, AL

    Background/Purpose: Descriptive study designed to assess compliance to evidence-based practice guidelines for the prevention of Glucocorticoid-Induced Osteoporosis (GIOP).Methods: We queried the electronic database of the…
  • Abstract Number: 0113 • ACR Convergence 2020

    Improving Glucocorticoid-Induced Osteoporosis Screening and Management in Patients with Rheumatic Diseases Using the 2017 ACR Guidelines

    Marielys Figueroa Sierra1, Atefeh Vafa1, Shu Cao2, Yuanyuan Lu3, Helen Bateman4, John Carter1, Yih Chang Lin2, Raquel Cuchacovich1, Marcos Maldonado4, Joanne Valeriano-Marcet1 and Gabriela Montes-Rivera4, 1University of South Florida, Tampa, FL, 2University of South Florida, Morsani College of Medicine, Tampa, FL, 3Biostatistician at Graduate Medical Education Department, Tampa, FL, 4James A. Haley VA, Tampa, FL

    Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is a potentially preventable complication in those who are maintained on glucocorticoid (GC) therapy.  It is imperative to identify these patients…
  • Abstract Number: 0115 • ACR Convergence 2020

    Improving Osteoporosis Screening in Men at a Resident-run Primary Care Clinic: A Quality Improvement Project

    Khiem Vu1, Chima Ohadugha1, Kevin Dao1, Rabih Nayfe2 and Andrew Mangano1, 1Grand Strand Medical Center, Myrtle Beach, SC, 2Carolina Health Specialists - Rheumatology, Myrtle Beach, SC

    Background/Purpose: There are known indications for osteoporosis screening in women. However, osteoporosis also occurs in men and fragility fractures are linked to increased morbidity and…
  • Abstract Number: 0540 • ACR Convergence 2020

    Risk of Hydroxychloroquine Retinopathy in the Community

    Jesse Dabit1, Mehmet Hocaoglu2, Kevin Moder1, Andrew Barkmeier3, Wendy Smith3, Thomas O'Byrne1, Cynthia Crowson4 and Ali Duarte-Garcia1, 1Mayo Clinic, Rochester, MN, 2University of Maryland Medical Center Midtown Campus, Baltimore, MD, 3Mayo Clinic, Rochester, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Hydroxychloroquine (HCQ) is used in the treatment of a wide variety of autoimmune diseases. HCQ retinopathy is a feared complication of long-term use. The…
  • Abstract Number: 0588 • ACR Convergence 2020

    Feast or Famine? An Institutional Assessment of Hydroxychloroquine Screening Practices

    Alanna James1, Kelli Kam1, Vaneet Sandhu2 and Christina Downey3, 1Loma Linda University Health, Loma Linda, CA, 2Loma Linda University, Loma Linda, CA, 3Loma Linda University Medical Center, Redlands, CA

    Background/Purpose: Hydroxychloroquine (HCQ) is a generally safe and widely used rheumatologic drug. Maculopathy is an adverse effect in < 1% in the first 5 years…
  • Abstract Number: 0620 • ACR Convergence 2020

    Do Physical Therapists Follow Evidence-Based Practice Recommendations for Treatment of Inflammatory Arthritides?

    Debbie Ehrmann Feldman1, Tatiana Orozco1, Sasha Bernatsky2, François Desmeules1, Maude Laliberté3, Kadija Perreault4, Jonathan El-Khoury5, Jean Légaré4 and Linda Woodhouse6, 1Université de Montréal, Montreal, QC, Canada, 2The Research Institute of the McGill University Health Centre, Montreal, ON, Canada, 3Integrated Health and Social Services University Network for West-Central Montreal, Montreal, Canada, 4Université Laval, Québec, QC, Canada, 5Université de Sherbrooke, Montreal, QC, Canada, 6Curtin University, Perth, Australia

    Background/Purpose: Physical therapy plays an important role in the global management of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Therapeutic exercises (mobility, strength and aerobic)…
  • Abstract Number: 1546 • 2018 ACR/ARHP Annual Meeting

    Efficacy and Safety of Corticosteroids in Rheumatoid Arthritis: Systematic Literature Review and Practical Recommendations

    Raimon Sanmartí1, Jesús Tornero Molina2, Francisco Javier Narváez3, Alejandro Muñoz4, Elena Garmendia5, Ana M. Ortiz Garcia6, Miguel A. Abad7, Patricia Moya8, Maria Lourdes Mateo9, Delia Reina10, Juan Salvatierra Osorio11, Sergio Rodriguez12, Ana Rubial Escribano13, Natalia Palmou-Fontana14 and Jaime Calvo-Alén15, 1Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain, 2Rheumatology Unit, Hospital de Guadalajara, Guadalajara, Spain, 3Rheumatology Department, Hospital Universitario de Bellvitge, Idibell, Barcelona, Spain, 4Rheumatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain, 5Rheumatology, Hospital Universitario Cruces. Barakaldo. Spain, Barakaldo, Spain, 6Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 7FEA Reumatología, Hospital Virgen del Puerto, Cáceres, Spain, 8Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 9Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, 10Rheumatology, Hospital Moises Broggi, Sant Joan Despí, Spain, 11Complejo Hospitalario Universitario de Granada, Granada, Spain, 12Rheumatology, Hospital Universitario Virgen de Valme, Sevilla, Spain, 13Rheumatology, Hospital Alfredo Espinosa, Urduliz, Spain, 14Hospital Universitario Marqués de Valdecilla, IDIVAL. Universidad of Cantabria, Santander, Spain, 15Rheumatology Department, Hospital Universitario Araba. Vitoria-Gasteiz, Alava, Spain

    Background/Purpose: Corticosteroids are effective in rheumatoid arthritis (RA) patients but their adverse events limit their use. The aim of this study was to: 1) To…
  • Abstract Number: 1102 • 2017 ACR/ARHP Annual Meeting

    Choosing Unwisely: HLA-B27 Testing and Adherence to Choosing Wisely Practices in a Large Integrated Academic Healthcare System

    Marc W. Nolan1,2, Morgan M. Brown3 and Elie Gertner1,2, 1Section of Rheumatology, Regions Hospital, St. Paul, MN, 2Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN, 3HealthPartners Institute, St. Paul, MN

    Background/Purpose: The ACR in 2013 and the Canadian Rheumatology Association (CRA) in 2015 published their respective Choosing Wisely recommendations to promote evidence-based care and reduce…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology